Clinicopathologic characteristics associated with undergoing CPM included a family history of breast cancer, age at diagnosis of breast cancer, white race, tested for BRCA1 or BRCA2 mutation, clinical tumor stage, and lobular histology as well as patients who underwent reconstructive surgery [25]. The gene discussed is BRCA2; the disease is neoplasm.